Philip Vitale - IsoRay Independent Director
| ISRDelisted Stock | USD 0.38 0.01 2.70% |
Director
Dr. Philip J. Vitale, M.D., is a Independent Director of IsoRay, Inc., since 2014. Dr. Vitale was also an Assistant Professor at the University of New Mexico, Division of Urology. He is a member of the American Urological Association and the South Central Section of the American Urological Association. Prior to his retirement, Dr. Vitales clinical trials included chemotherapy after prostatectomy a phase III randomized study for high risk prostate carcinoma RTOG 0415 a phase III randomized study of hypofractionated 3dcrtIMRT versus conventionally fractionated 3dcrtIMRT in patients with favorablerisk prostate cancer RTOG 0815 a phase III prospective randomized trial of doseescalated radiotherapy with or without shortterm androgen deprivation therapy for patients with intermediaterisk prostate cancer and YP19A1 gene and pharmacogenetics of response to testosterone therapy. Dr. Vitale holds a B.A. in Biology from LaSalle College and obtained his M.D. from the New Jersey College of Medicine and Dentistry. He received his M.S. in Health Services Administration from the College of St. Francis. Dr. Vitale brings to the Board medical expertise in the industries the Company is targeting. since 2014.
| Age | 72 |
| Tenure | 10 years |
| Phone | 509 375 1202 |
| Web | https://isoray.com |
IsoRay Management Efficiency
The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| John Murphy | Summit Materials | 70 | |
| Antonio Maciel | Marfrig Global Foods | N/A | |
| Brian Geary | Highway Holdings Limited | 56 | |
| Ian Hill | Marfrig Global Foods | 64 | |
| Marcia Santos | Marfrig Global Foods | N/A | |
| Stanley Sheridan | National Beverage Corp | 73 | |
| Joseph Cantie | Summit Materials | 57 | |
| Neil Simpkins | Summit Materials | 51 | |
| Samuel Hathorn | National Beverage Corp | 73 | |
| Steven Wunning | Summit Materials | 70 | |
| Shlomo Tamir | Highway Holdings Limited | 66 | |
| Herculano Alves | Marfrig Global Foods | 62 | |
| Rodrigo Marcal | Marfrig Global Foods | N/A | |
| Kuang Yang | Highway Holdings Limited | 56 | |
| Ernesto Lozardo | Marfrig Global Foods | N/A | |
| Alain Martinet | Marfrig Global Foods | 66 | |
| Wing Leung | Highway Holdings Limited | 60 | |
| Julia Kahr | Summit Materials | 37 | |
| Marcelo Correa | Marfrig Global Foods | N/A | |
| Fabio Vasconcellos | Marfrig Global Foods | N/A | |
| Susan Ellerbusch | Summit Materials | 53 | |
Management Performance
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 |
IsoRay Inc Leadership Team
Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller | ||
| Alan Hoffmann, Independent Director | ||
| Lisa Lauer, Vice President - Business Development | ||
| Lori Woods, Interim Chief Executive Officer, Director | ||
| Michael McCormick, Independent Chairman of the Board | ||
| Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer | ||
| Thomas LaVoy, Independent Director | ||
| William Cavanagh, Vice President - Research and Development | ||
| Lori HolmesWoods, CEO Director | ||
| Michael Krachon, Vice President, Director of Sales and Marketing | ||
| Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources | ||
| Mark CPA, Controller, Fin | ||
| William III, Chief Officer | ||
| Philip Vitale, Independent Director | ||
| Krista Cline, Senior Director of Operations, Corporate Secretary | ||
| Matthew Branson, Principal Financial Officer | ||
| Patricia Mills, NE Area Sales Director | ||
| Brien Ragle, CFO |
IsoRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.21) % | |||
| Current Valuation | (11.02 M) | |||
| Shares Outstanding | 278.66 M | |||
| Shares Owned By Insiders | 0.76 % | |||
| Shares Owned By Institutions | 6.18 % | |||
| Number Of Shares Shorted | 409.25 K | |||
| Price To Earning | (5.00) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |